97 related articles for article (PubMed ID: 14666203)
1. Colorimetric in vitro evaluation of T-cell cytotoxicity.
Khromykh LM; Anfalova TV; Kazanskii DB
Bull Exp Biol Med; 2003 Sep; 136(3):314-7. PubMed ID: 14666203
[TBL] [Abstract][Full Text] [Related]
2. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies.
Zhi-Jun Y; Sriranganathan N; Vaught T; Arastu SK; Ahmed SA
J Immunol Methods; 1997 Dec; 210(1):25-39. PubMed ID: 9502582
[TBL] [Abstract][Full Text] [Related]
3. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.
Ahmed SA; Gogal RM; Walsh JE
J Immunol Methods; 1994 Apr; 170(2):211-24. PubMed ID: 8157999
[TBL] [Abstract][Full Text] [Related]
4. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.
Nociari MM; Shalev A; Benias P; Russo C
J Immunol Methods; 1998 Apr; 213(2):157-67. PubMed ID: 9692848
[TBL] [Abstract][Full Text] [Related]
5. A new non-radioactive method for IL-2 bioassay.
Kwack K; Lynch RG
Mol Cells; 2000 Oct; 10(5):575-8. PubMed ID: 11101150
[TBL] [Abstract][Full Text] [Related]
6. An improved colorimetric assay for T cell cytotoxicity in vitro.
Müllbacher A; Parish CR; Mundy JP
J Immunol Methods; 1984 Mar; 68(1-2):205-15. PubMed ID: 6323582
[TBL] [Abstract][Full Text] [Related]
7. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
Apolloni E; Bronte V; Mazzoni A; Serafini P; Cabrelle A; Segal DM; Young HA; Zanovello P
J Immunol; 2000 Dec; 165(12):6723-30. PubMed ID: 11120790
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
Leshem B; Kedar E
J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
[TBL] [Abstract][Full Text] [Related]
9. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
10. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
[TBL] [Abstract][Full Text] [Related]
12. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
13. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.
Malek TR; Yu A; Scibelli P; Lichtenheld MG; Codias EK
J Immunol; 2001 Feb; 166(3):1675-83. PubMed ID: 11160210
[TBL] [Abstract][Full Text] [Related]
14. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
Fan J; Bonavida B
J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cell viability using time-dependent increase in fluorescence intensity.
Hamalainen-Laanaya HK; Orloff MS
Anal Biochem; 2012 Oct; 429(1):32-8. PubMed ID: 22796501
[TBL] [Abstract][Full Text] [Related]
16. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
17. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
Okada M; Henney CS
J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
[No Abstract] [Full Text] [Related]
18. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
19. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
20. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability.
Larson EM; Doughman DJ; Gregerson DS; Obritsch WF
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1929-33. PubMed ID: 9331256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
